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Insights into the Roles of Desolvation and n:-Electron 
Interactions during DNA Polymerization 
Edward A. Motea, Irene Lee, and Anthony J. Berdis 
This report describes the use of several isosteric non-natural 
nucleotides as probes to evaluate the roles of nucleobase 
shape, size, solvation energies, and n-electron interactions as 
forces influencing key kinetic steps of the DNA polymerization 
cycle. Results are provided using representative high- and low-
fidelity DNA polymerases. Results generated with the f. coli 
Kienow fragment reveal that this high-fidelity polymerase uti-
lizes hydrophobic nucleotide analogues with higher catalytic 
efficiencies compared to hydrophilic analogues. These data 
support a major role for nucleobase desolvation during nucleo-
tide selection and insertion. In contrast, the low-fidelity HIV-
1 reverse transcriptase discriminates against hydrophobic ana-
logues and only tolerates non-natural nucleotides that are ca-
Introduction 
DNA polymerases catalyze the addition of mononucleotides 
into a growing polymer (primer), typically using a DNA tem-
plate as a guide to direct each incorporation event. The chemi-
cal mechanism for DNA polymerization is simple nucleophilic 
attack by the 3'-0H of the primer on the a-phosphate of the 
incoming dNTP. Although the chemical mechanism of this re-
action is well defined,111 there still remain many questions re-
garding the molecular details of kinetic steps that precede the 
phosphoryl transfer step. For example, how do polymerases 
accurately read a DNA template strand to decide which of the 
four natural dNTPs should be correctly incorporated into the 
growing primer? This is an important question as DNA is heter-
opolymeric, and the changing nature of the templating strand 
places additional strains on the unusually high demand for 
substrate specificity to maintain genomic fidelity. Paradoxically, 
polymerases must be highly selective to insert only one of four 
potential dNTPs opposite a templating nucleobase while also 
being extraordinarily flexible to recognize distinct pairing part-
ners. Furthermore, a polymerase must perform the repetitive 
task of nucleobase pairing and phosphodiester bond formation 
with incredible speed.£21 
pable of hydrogen-bonding or n-stacking interactions. Surpris-
ingly, hydrophobic analogues that function as efficient sub-
strates for the £ coli Kienow fragment behave as noncompeti-
tive or uncompetitive inhibitors against HIV-1 reverse transcrip-
tase. In these cases, the mode of inhibition depends upon the 
absence or presence of a templating nucleobase. Molecular 
modeling studies suggest that these analogues bind to the 
active site of reverse transcriptase as well as to a nearby hydro-
phobic binding pocket. Collectively, the studies using these 
non-natural nucleotides reveal important mechanistic differen-
ces between representative high- and low-fidelity DNA poly-
merases during nucleotide selection and incorporation. 
Several models, including positive/negative selection.r31 ther-
modynamic stability}41 and steric constraints/shape comple-
mentarity,151 have been proposed to account for how poly-
merases maintain fidelity during DNA synthesis. While each 
model invokes distinctive features, they all argue that the func-
tional groups present on the nucleobases are important for 
efficient polymerization. Indeed, these functional groups regu-
late polymerization efficiency and fidelity by consummating 
proper hydrogen-bonding interactions between the incoming 
nucleotide and the templating nucleobase. However, the reli-
ance on hydrogen-bonding as the sole factor influencing effi-
cient DNA synthesis has been challenged by the demonstra-
tion that non-natural nucleotides lacking classical hydrogen-
bonding groups are viable polymerase substrates.161 Perhaps 
the most-cited example of this observation is the demonstra-
tion that 2,4-difluorotoluene, an isosteric analogue of dTIP, is 
enzymatically incorporated opposite a templating adenine 
with remarkably high efficiency.16a1 While these studies provide 
compelling evidence that DNA polymerization can indeed 
occur in the absence of hydrogen-bonding potential, there still 
remain several questions regarding how other biophysical fea-
tures such as shape/size, nucleobase hydrophobicity, and n-
electron interactions are used during polymerization. 
To more accurately examine these features, we developed 
a series of 5-substituted indolyl-2'-deoxynucleotides as mecha-
nistic probes for the replication of normal DNA in addition to 
several distinct DNA lesions.[7) For example, the isosteric non-
natural nucleotides illustrated in Figure 1 A were employed to 
study how the high-fidelity bacteriophage T4 DNA polymerase 
uses nucleobase hydrophobicity and n-electron interactions 
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Figure 1. A) Chemical structure and physicochemical properties of non natural nucleo 
tides used in this study. For clarity, only the nucleobases are shown. Surface areas (used 
as an indicator of the relative size of the nucleobase), Clog P and electrostatic density po 
tential map shown for each nucleobase were calculated using the Spartan '08 software. 
The semi empirical method of calculation with AM1 was used for geometry optimization 
and the density functional theory level of calculation with B3LYP 6 31 G** basis sets were 
used for energy minimization. B) DNA substrate sequence used in this study. C) The in 
corporation of natural (dATP) and various non natural nucleotides opposite an abasic site 
catalyzed by the E.coli Kienow fragment. Aliquots of the reaction were quenched using 
EDTA (200 mM). The total reaction time was 5 min. D) The utilization of natural (dATP) 
and various non natural nucleotides opposite an abasic site catalyzed by HIV 1 RT. Ali 
quots of the reaction were quenched using EDTA (200 mM). The total reaction time was 
60 min. See text for complete details regarding experimental conditions. 
cilitates the conformational change step preceding 
phosphoryl transfer. 
It should be noted that this previous study em-
ployed the bacteriophage T4 DNA polymerase, a pro-
totypical family B member of DNA polymerases that 
is recognized for its remarkable high fidelity when 
replicating undamaged DNA.[9l This report attempts 
to extend these findings by quantifying the ability of 
different DNA polymerases, the E. coli Kienow frag-
ment (family A) and HIV-1 reverse transcriptase 
(family RT), to utilize these non-natural nucleotides 
when replicating normal DNA or an abasic site. The 
goal is to determine if nucleobase desolvation and 
Jt-electron interactions play similar roles with these 
other DNA polymerases. Indeed, the results present-
ed here indicate that DNA polymerization does not 
occur through a "universal" mechanism. Instead, 
DNA polymerases utilize distinct biophysical features 
when replicating normal and damaged forms of 
DNA. This is evident as the f. coli Kienow fragment 
and HIV-1 RT show unique behavior when utilizing 
these different classes of isosteric non-natural nucle-
otides. In general, HIV-1 RT shows higher discrimina-
tion against incorporating non-natural nucleotide 
analogues opposite an abasic site or templating 
DNA compared to the Kienow fragment. This dichot-
omy can be explained by significant differences in 
the composition and architecture of the active sites 
of each DNA polymerase. In addition, these non-nat-
ural nucleotides display unique inhibitory effects 
against HIV-1 RT. Collectively, this information pro-
vides new insights into the mechanism of DNA poly-
merization as well as applications towards develop-
ing novel inhibitors against viral DNA polymerases. 
Results 
HIV-1 RT and f. coli Kienow fragment replicate an 
abasic site through distinct mechanisms 
Our studies begin by using the isosteric non-natural 
nucleotides shown in Figure 1 A to quantify the con-
tributions of shape, size, nucleobase desolvation, 
and n-electron interactions when replicating an 
abasic site. We focused on this lesion as the lack of 
during the replication of normal DNA and an abasic site, 
a non-instructional DNA lesion.l81 The first class of analogues 
(5-NITP, 5-CITP, and 5-MeCITP) were used to quantify the role 
of nucleobase hydrophobicity and desolvation. The second 
class (5-PhlTP, 5-FS-PhlTP, and 5-F40Me-PhlTP) were used to 
evaluate the importance of n-electron density and size varia-
tion. Collectively, this study demonstrated that the catalytic ef-
ficiency, kp0i/Kd,app• for incorporating these non-natural nucleo-
tides is governed by their intrinsic hydrophobicity and degree 
of Jt-electron density_l81 This information was used to propose
a model in which the binding affinity of the nucleotide is con-
trolled by nucleobase desolvation while n-electron density fa-
coding information minimizes the influence of direct hydro-
gen-bonding interactions during kinetic steps encompassing 
nucleotide binding, conformational changes, and phosphoryl 
transfer. In addition, the use of 5-substituted indolyl-2'-deoxy-
nucleotides is an important way of quantifying the influence of 
the aforementioned biophysical features. For example, ana-
logues such as 5-NITP, 5-CITP, and 5-MeCITP are nearly identical 
with respect to overall shape/size and n-electron density (Fig-
ure 1 A and Table 51 in the Supporting Information). However, 
since 5-CITP is far more hydrophilic than 5-NITP and 5-MeCITP, 
variations in its utilization can be attributed to differences as-
sociated with nucleobase hydrophobicity. Similar arguments 
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Table 1. Summary of kinetic parameters for the incorporation of natural and non natural nucleotides opposite 
k,a/Km values increase from the 
lowest value of 3200 M- 1 s- 1 for 
the small analogue, 5-CITP, to 
the highest value of 
235000M-1s_, measured with 
the largest analogue, 5-F40Me-
PhlTP. This result is consistent 
with previous reports indicating 
that large analogues such as 5-
cyclohexyl-2' -deoxynucleoside 
triphosphate (5-CHITP) are uti-
lized with higher efficiencies 
compared to smaller analogues 
such as indolyl-2'-deoxynucleo-
side triphosphate (lndTP).!10aJ 1 
an abasic site catalyzed by the E.coli Kienow fragment1'1 or HIV 1 RT1b1• 
Polymerase Analogue Km [µM] kca, [s 1] kca/ Km [M 1 s '] 
KF dATP 3 4 ± 6  0.18±0.01 5290 
KF 5 NITP 8 ± 2  0.24±0.02 30000 
KF 5 CITP 125±30 0.40±0.03 3200 
KF 5 MeCITP 5.4±0.7 0.6±0.1 111 000 
KF 5 PhlTP 14.3±0.3 0.42±0.04 29400 
KF 5 FS PhlTP 3.0±0.4 0.40±0.01 133300 
KF 5 F40Me PhlTP 2.6±0.4 0.61 ±0.03 234600 
RT dATP 70±13 0.0093 ± 0.0008 133 
RT 5 NITP 58±18 0.0084 ± 0.0006 145 
RT 5 CITP n.d.lcl n.d. n.d. 
RT 5 MeCITP 106±35 0.0058 ± 0.0002 55 
RT 5 PhlTP n.d. n.d. n.d. 
RT 5 FS PhlTP n.d. n.d. n.d. 
RT 5 F40Me PhlTP n.d. n.d. n.d. 
[al Assays were performed using Kienow fragment (12 nM) and DNA substrate (1000 nM) with variable nucleo 
However, closer inspection of 
the individual k,at and Km param-
eters do not support a steric fit 
model as there is not a clear 
correlation between the shape/ 
size of a non-natural nucleotide 
tide concentrations (0 500 µM). [bl Assays were performed using of HIV 1 reverse transcriptase (SO nM) and 
DNA substrates (500 nM) with variable nucleotide concentrations (0 500 µM). [cl Not determined as incorpora 
tion was too low to measure accurately even at the highest nucleotide concentration used (500 µM). n.d.: not 
determined. 
can be made using 5-PhlTP and the fluorinated analogues, 5-
F5-PhlTP and 5-F40me-PhlTP, to evaluate the roles of :rt-elec-
tron interactions. 
The ability of Kienow fragment and HIV-1 RT to incorporate 
nucleotides opposite an abasic site was tested using the DNA 
substrate depicted in Figure 1 B. Denaturing gel electrophoresis 
images provided in Figure 1 C and D show that dATP is utilized 
by both DNA polymerases, and this result is consistent with 
previous reports_!,oJ Despite this similarity, however, the two 
polymerases differ in their ability to utilize the non-natural nu-
cleotides examined here. For example, the Kienow fragment 
incorporates all six non-natural nucleotides opposite the non-
instructional abasic site while HIV-1 RT only incorporates two 
of the six analogues (5-NITP and 5-MeCITP). This later result is 
surprising since HIV-1 RT typically displays low fidelity and was 
thus predicted to utilize all of these non-natural nucleotides, 
especially 5-PhlTP which has enhanced base-stacking proper-
tiesY 1l 
To further assess this dichotomy, k,av Km , and k,a/Km values 
for these non-natural nucleotides were measured using both 
DNA polymerases. These parameters, summarized in Table 1, 
indicate that the E.coli Kienow fragment and HIV-1 RT differ 
mechanistically as they rely on different biophysical features to 
select and incorporate nucleotides opposite an abasic site. In 
the sections below, the distinctive features of each DNA poly-
merase are discussed regarding their ability to utilize or dis-
criminate against these novel non-natural nucleotides. 
The importance of nucleobase desolvation with the E. coli 
Kienow fragment 
At face value, the data appear to support a model invoking 
steric constraints/shape complementarity as the overall catalyt-
ic efficiencies (k,a/Kml for nucleotide utilization correlates with 
the size and shape of the non-natural nucleotide. For example, 
with its Km value. Instead, the 
hydrophobicity of the non-natural nucleobase appears to play 
a large role in influencing Km . This is evident as the Km value of 
8 µM for the hydrophobic analogue, 5-NITP, is significantly 
lower than the Km value of 125 µM measured for the hydrophil-
ic analogue, 5-CITP. In this case, the 16-fold higher Km value for 
5-CITP must reflect differences in nucleobase hydrophobicity 
since both analogues are essentially identical with respect to 
size, shape, and :rt-electron density. This mechanism is further 
supported as the Km value for the other hydrophobic analogue, 
5-MeCITP, is - 25-fold lower than its hydrophilic counterpart, 5-
CITP (compare 5.4 µM versus 125 µM, respectively). Similar ob-
servations were reported with the high-fidelity bacteriophage 
T4 DNA polymerase/8l and this commonality suggests that 
nucleobase hydrophobicity plays a vital role in the binding 
affinity of the incoming nucleotide with members of the A and 
B families of DNA polymerases. 
This mechanism was further investigated by comparing the 
kinetic parameters for the isosteric analogues, 5-PhlTP, 5-F5-
PhlTP, and 5-F40Me-PhlTP. These analogues are similar in 
shape and size but differ with respect to the degree of :rt-elec-
tron density. Previous studies with the bacteriophage T4 DNA 
polymerase showed that the :rt-electron-rich nucleotide, 5-
PhlTP, was utilized as efficiently as the :rt-electron-deficient ana-
logues, 5-F5-PhlTP and 5-F40Me-PhlTP.!8l With the Kienow frag-
ment, however, both 5-F5-PhlTP and 5-F40Me-PhlTP display 
higher k,a/Km values compared to 5-PhlTP. Rather than influ-
encing k,at• these fluorinated analogues have lower Km values 
compared to 5-PhlTP (compare 3.0 µM for 5-F5-PhlTP and 
2.6 µM for 5-F40Me-PhlTP versus 14.3 µM for 5-PhlTP). Since 
these fluorinated nucleotides are more hydrophobic than their 
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Table 2. Summary of kinetic parameters for the incorporation of natural and non natural nucleotides opposite 
PhlTP, and 5-F40Me-PhlTP), and 
again contrast results obtained 
with the Kienow fragment. 
a thymine template catalyzed by the Kienow fragment1'1 or HIV 1 reverse transcriptase 1b1• 
Polymerase Analogue Km [µM)] k," [s 1] kca/ Km [M 
1 S 1] 
KF dATP' 5 ± 1  5 0 ± 5  10000000 
KF 5 NITP 3 4 ± 8  0.0042 ± 0.0002 120 Non-natural nucleotides are 
unique HIV-1 RT inhibitors KF 5 CITP n.d_ldl n.d. n.d. 
KF 5 MeCITP 50±13 0.007 ± 0.001 140 
KF 5 PhlTP 21 ± 4 0.005 ± 0.001 240 The inability of HIV-1 RT to in-
corporate non-natural nucleo-
tides could result from a lack of 
nucleotide binding or by an in-
ability of these analogues, once 
bound to the Pol-DNA com-
plex, to induce a conformational 
change necessary for phospho-
ryl transfer. These possibilities 
were examined by testing the 
inhibitory effects of these ana-
logues against HIV-1 RT during 
the replication of an abasic site 
or normal DNA. The data pro-
KF 5 FS PhlTP 94±22 0.011 ±0.001 120 
KF 5 F40Me PhlTP 2 4 ± 5  0.01 0 ± 0.001 420 
RT dATP 0.41 ±0.07 0.084 ± 0.004 205000 
RT 5 NITP n.d. n.d. n.d. 
RT 5 CITP n.d. n.d. n.d. 
RT 5 MeCITP n.d. n.d. n.d. 
RT 5 PhlTP n.d. n.d. n.d. 
RT 5 FS PhlTP n.d. n.d. n.d. 
RT 5 F40Me PhlTP n.d. n.d. n.d. 
[a] Assays were performed using Kienow fragment (60 nM) and DNA substrate (1000 nM) with variable nucleo 
tide concentrations (0 500 µM). [bl Assays were performed using HIV 1 reverse transcriptase (SO nM) and DNA 
substrates (500 nM) with variable nucleotide concentrations (0 500 µM). [cl Kinetic values taken from [1 OJ. 
[d] Not determined as the amount of nucleotide incorporation was too low to measure accurately even at the 
highest nucleotide concentration tested (500 µM). n.d.: not determined. 
nonfluorinated counterpart,l1 2l their lower K m values again sup-
port an important role for nucleobase desolvation as a key 
determinant for efficient nucleotide incorporation opposite an 
abasic site. 
The k,.,, Km, and k , . / Km values for these isosteric non-natural 
nucleotides were also measured for incorporation opposite 
a templating thymine. As summarized in Table 2, the presence 
of thymine markedly reduces their catalytic efficiencies. This 
occurs as both the k,at and K m values are adversely influenced, 
and these effects are consistent with models invoking steric fit 
and shape complementarity as important features for normal 
DNA replication_[sJ In general, these data argue that steric fit/ 
shape complementarity play important roles for nucleotide se-
lection by the E. coli Kienow fragment during normal DNA syn-
thesis. However, nucleobase hydrophobicity plays a larger role 
during the replication of non-instructional DNA lesions such as 
an abasic site. 
HIV-1 RT requires enthalpic interactions for nucleotide 
incorporation 
Identical kinetic analyses were performed using HIV-1 RT, 
a low-fidelity DNA polymerase, to quantify the incorporation of 
these isosteric analogues opposite normal and damaged DNA. 
The data summarized in Table 1 highlight several important 
mechanistic differences between HIV-1 RT and the E.coli 
Kienow fragment. As described earlier, HIV-1 RT utilizes only 
two non-natural nucleotides, 5-NITP and 5-MeCITP, during the 
replication of an abasic site. In addition, both analogues dis-
play low catalytic efficiencies that are essentially identical to 
the natural substrate, dATP. These results contrast those ob-
tained with the Kienow fragment which displays higher catalyt-
ic activity with these non-natural nucleotides. Finally, HIV-1 RT 
does not utilize large, hydrophobic analogues (5-PhlTP, 5-FS-
vided in Figure 2A shows that 
dAMP incorporation opposite an abasic site is progressively 
inhibited with increasing concentrations of 5-CITP. Dixon plot 
analysis yields an apparent K; value of (19 ± 4) µM for 5-CITP 
(Figure 2 B), and correction for the concentration of the natural 
substrate using the Cheng-Prusoff equation [13J yields a true K; 
value of (8.1 ±1.7) µM. Similar analyses yield a K; value of (7.9± 
2.4) µM for 5-PhlTP opposite the abasic site (Table 3). In gener-
al, the inhibitory effects produced by these non-natural nucleo-
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so 100 150 200 250 300 
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Figure 2. Inhibition of HIV 1 RT activity by 5 CITP. A) Representative time 
courses for the incorporation of dATP opposite an abasic site in the absence 
and presence of varying 5 CITP inhibitor concentrations. The concentration 
of 5 CITP is denoted by the following: 0 µM (o), 15 µM (•), 30 µM (o), and 
45 µM (el nucleotide. B) Dixon plot analysis yields an apparent K; of 19 µM. 
The true K; value of (8.1 ± 1.7) µM was obtained using the Cheng Prusoff 
equation. 
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Table 3. Summary of  inhibition constants and mode of  inhibition for non natural nucleotides against HIV 1 RT 
is expected to hinder binding of 
the non-natural nucleotide. Un-
fortunately, this simple explana-
tion is incomplete as the mea-
sured K; values do not correlate 
with the size and/or shape of 
the corresponding non-natural 
nucleotides. For example, the K; 
values for 5-CITP and 5-MeCITP, 
which are predicted to be ade-
quate pairing partners for thy-
mine, are higher than that mea-
sured for 5-PhlTP, a larger ana-
logue that should not properly 
transcriptase during translesion and correct DNA synthesis. 
Template Inhibitor K, [µM] Mode of inhibition 
abasic site 5 CITP 8.1 ±1.7 
abasic site 5 CITP competitive 
abasic site 5 PhlTP 7.9±2.4 
abasic site 5 PhlTP noncompetitive 
thymine 5 CITP 44±14 
thymine 5 CITP competitive 
thymine 5 PhlTP 3 2 ± 7  
thymine 5 PhlTP uncompetitive 
thymine 5 NITP 2 6 ±  11 
thymine 5 MeCITP 86±13 
n.a.: not applicable. 
tides validate that they bind to HIV-1 RT but are unable to 
interact productively for catalysis. However, the identity in the 
inhibition constants for 5-CITP and 5-PhlTP is surprising as 
these analogues differ significantly with respect to shape, size, 
and nucleobase hydrophobicity. 
The inhibition constants for 5-CITP, 5-PhlTP, 5-NITP, and 5-
MeCITP were next measured during the replication of thymine 
to further elucidate the mechanism of nucleotide binding. As 
expected, each analogue inhibits dAMP incorporation (Table 3). 
In addition, the K; values measured opposite a templating base 
are -fivefold higher than those measured opposite the non-
templating abasic site. The difference in potency could reflect 
simple steric hindrance as the presence of the templating base 
A) 40
-0.0125 -0.0075 -0.0025 0.0025 
1/[dATP] / µM-1 
C) 
-0.0125 -0.0075 -0.0025 0.0025 
1/[dATP] / µM-1 
0.0075 
0.0075 
45 µM 5-CITP 
30 µM 5-CITP 
15 µM 5-CITP 
0 µM 5-CITP 
0.0125 
60 µM 5-PhlTP 
30 µM 5-PhlTP 
15 µM 5-PhlTP 
0 µM 5-PhlTP 
0.0125 
K,, [µM] Kii [µM] 
11.0±1.1 n.a. 
20.1 ±1.2 30.6±1.1 
18.8±0.3 n.a. 
n.a. 27.0± 1.6 
pair with thymine. 
Double reciprocal plot analyses were next performed to 
define the mode of inhibition for several of these nucleotide 
analogues. Representative data provided in Figure 3 A shows 
that the hydrophilic nucleotide, 5-CITP, behaves as a competi-
tive inhibitor versus dATP when replicating an abasic site. This 
analysis yields a K;, value of (11.0 ± 1.1) µM which is in excellent 
agreement with the K; value of (8.1 ± 1.7) µM measured above 
using Dixon plot analysis (vide supra). Likewise, 5-CITP acts as 
a competitive inhibitor versus dATP during normal DNA syn-
thesis, displaying a higher K;, of (18.8 ± 0.3) µM. 
Similar analyses performed with 5-PhlTP show that this non-
natural nucleotide behaves as a noncompetitive inhibitor 
versus dATP during the replication of an abasic site (Figure 3 C). 
B) 3
-2.00 -1.00 0.00 
1/[dATP] / µM-1 
D) 1.8 
-2.50 -1.50 -0.50 0.50 
1/[dATP] / µM-1 
1.00 
1.50 
60 µM 5-CITP 
45 µM 5-CITP 
30 µM 5-CITP 
OµM 5-CITP 
2.00 
120 µM 5-PhlTP 
60 µM 5-PhlTP 
30 µM 5-PhlTP 
OµM 5-PhlTP 
2.50 
Figure 3. Double reciprocal plot analyses used to define the mode of inhibition by 5 CITP and 5 PhlTP against HIV 1 RT. dATP incorporation opposite an 
abasic site or a thymine template. A) 5 CITP acts as a competitive inhibitor against dATP incorporation opposite an abasic site (DNA5,). B) 5 CITP acts as a com 
petitive inhibitor against dATP incorporation opposite a templating thymine (DNAr). C) 5 PhlTP acts as a noncompetitive inhibitor against dATP incorporation 
opposite an abasic site. D) 5 PhlTP acts as an uncompetitive inhibitor against dATP incorporation opposite a templating thymine (DNAr). 
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This contrasts the competitive inhibition observed with 5-CITP 
and indicates that 5-PhlTP binds to two different sites on the 
polymerase. l141 Fits of the data to Equation (6) provide a K;, 
value of (20.1 ± 1.2) µM which likely corresponds to the binding 
of 5-PhlTP to the RT-DNAsp binary complex and a K; value of 
(30.6 ± 1.1) µM which represents 5-PhlTP binding to a different 
enzyme form, most likely the RT-DNAsp-dATP ternary complex. 
This model was validated by defining the mode of inhibition 
during the replication of undamaged DNA. As illustrated in Fig-
ure 3 D, the inhibition pattern of 5-PhlTP changes from non-
competitive during the replication of an abasic site to uncom-
petitive during the replication of undamaged DNA. In this 
case, the K; value of (27.0 ± 1.6) µM is nearly identical to the K; 
value of (30.6 ± 1.1) µM measured using DNA containing an 
abasic site, and this suggests that 5-PhlTP inhibits the retroviral 
polymerase by binding to a potential allosteric site. 
Molecular modeling studies 
The dichotomy in nucleotide utilization between these DNA 
polymerases was explored using existing structural informa-
tion l151 to compare the amino acid composition and architec-
ture of their active sites within 5 A of the primer-template 
junction. As illustrated in Figure 4 A, the active site of the 
Kienow fragment contains two aromatic amino acids, F762 and 
Y766, that lie approximately 4 A away from the primer termi-
nus. Figure 4 B shows that the same region of HIV-1 RT is con-
siderably different as R72 and Ql 51 occupy sites that are 
equivalent to F762 and Y766, respectively, in the Kienow frag-
ment. Although these polar and hydrophilic amino acids have 
been implicated in stabilizing the transition state during phos-
phoryl transfer/161 our analysis here suggests a potential role in 
nucleotide selection and/or conformational changes associated 
with polymerization. 
Discussion 
Hydrogen-bonding, steric constraints, nucleobase hydropho-
bicity, desolvation energies, n-n stacking, and n-cation stacking 
interactions play important roles in defining the double helical 
nature of DNA. However, quantifying their contributions 
during various enzymatic processes such as DNA replication 
and DNA repair has proven to be difficult. Much of this difficul-
ty arises from the intrinsic properties of natural nucleotides as 
they typically possess differing "amounts" of each biophysical 
feature. For example, guanine possesses a larger surface area 
than adenine and has more functional groups capable of 
hydrogen-bonding interactions. However, adenine has better 
base-stacking capabilities compared to guanine due to its 
more aromatic and hydrophobic nature. These differences 
make it difficult to unambiguously define the roles of these 
features. To combat these complications, recent efforts have 
focused on using non-natural nucleotides, that is, nucleotide 
analogues with non-hydrogen bonding groups, as artificial 
substrates to more accurately define the influence of these fea-
tures during DNA polymerization. The strategy of this ap-
proach is to selectively introduce diverse functional groups at 
a defined position of a simple molecular scaffold that mimics 
a purine or pyrimidine. l6a-gJ a-cJ For example, we recently devel-
oped two classes of isosteric non-natural nucleotides to probe 
the mechanism of polymerization catalyzed by the high-fidelity 
bacteriophage T4 DNA polymerase. l81 These studies demon-
strated that the initial binding step of the non-natural nucleo-
tide is governed by energies involving nucleobase desolvation 
while the conformational change step preceding phosphoryl 
transfer is controlled by a combination of nucleobase hydro-
phobicity and n-electron density. In the present study, we 
investigated if this model can be accurately applied to other 
DNA polymerases such as HIV-1 RT and the E. coli Kienow frag-
ment. The results here indicate that a "universal" mechanism 
does not exist, at least in the context of using 5-substituted-in-
dolyl-2' -deoxynucleotides. In fact, the use of these non-natural 
analogues provides some unexpected results that illustrate the 
molecular diversity used by each enzyme to achieve efficient 
DNA polymerization. For instance, it is surprising that the 
"error-prone" HIV-1 RT shows a remarkable ability to discrimi-
nate against using nucleotide analogues that lack canonical 
hydrogen-bonding groups. These results differ from those re-
Surface color 
hydrophobic hydrophilic 
Figure 4. Kyte Doolittle hydrophobicity surface structural models for A) Kienow fragment and B) HIV 1 RT. These models were generated using UCSF Chi 
mera 1.5.3. The abasic site was created through PyMol builder from the crystal structure of the ternary complex HIV 1 RT DNA dATP (PDB ID: 3KK2). The pu 
tative ternary complex of the Kienow fragment was modeled from the crystal structure of KlenTaq polymerase (PDB ID 3LWL) using the Molecular Operating 
Environment (MOE 2010.10) package as described in the Experimental Section. 
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ported by Kool's group who demonstrated that HIV-1 RT can 
efficiently incorporate several nonpolar isosteric analogues of 
dTIPY 7J The reason for this kinetic difference is currently un-
known. However, one possibility could reflect intrinsic differen-
ces between using small, non-natural analogues such as disub-
stituted toluene derivatives versus larger 5-substituted-indolyl-
2'-deoxynucleotides. Another difference could reflect the in-
fluence of functional groups that are more chemically diverse 
( N02, CO2, and COOCH 3) compared to simple halogens ( F, 
Cl, and Br). While these differences warrant further investi-
gations, the inability of HIV-1 RT to utilize our 5-substituted 
indolyl-2'-deoxynucleotides is particularly interesting as the 
Kienow fragment, a polymerase with higher intrinsic fidelity, 
incorporates these hydrophobic non-natural nucleotides oppo-
site a templating thymine (Table 2). 
The kinetic preference of the E. coli Kienow fragment to use 
non-natural nucleotides during the replication of an abasic site 
appears very similar to that for the high-fidelity bacteriophage 
T4 DNA polymerase. In fact, both polymerases preferentially 
utilize non-natural nucleotides that have strong base-stacking 
properties, i.e., analogues that are hydrophobic and rich in n-
electron density. This is evident as the Kienow fragment and 
T4 DNA polymerase both incorporate 5-NITP opposite an 
abasic site much more efficiently than the preferred natural 
nucleotide, dATP_l10•, isi However, comparison of structural data 
from the Thermus aquaticus KlenTaq polymerase 119l and the 
bacteriophage RB69 DNA polymerase120J reveal different inter-
actions of 5-NITP within the active site of either enzyme, The 
structure of the RB69 DNA polymerase bound to an abasic-site 
containing DNA and 5-NITP shows that the non-natural nucleo-
tide exists in an intrahelical position. In this conformation, the 
nitro moiety extends into the void of the abasic site such that 
the non-natural nucleobase stacks under the template strand. 
This structural data indicates that steric constraints do not play 
a significant role in nucleotide selection. Instead, nucleobase 
hydrophobicity and n-n  interactions of the nitroindole moiety 
with the penultimate base pair play the predominant roles. 
Furthermore, when paired opposite an abasic site, the indole 
ring of the non-natural nucleotides is superimposable with the 
adenine ring of dATP when it is present in a Watson-Crick 
base pair with thymine, Thus, the RB69 polymerase structure 
shows that 5-NITP adopts a "normal" conformation in DNA, 
even when incorporated opposite a nontemplating abasic site. 
Results obtained with the T. aquaticus KlenTaq polymerase 
offer a different interpretation for the enhanced incorporation 
kinetics for 5-NITP opposite the lesion.119J In this case, the inter-
action of natural nucleotides including dATP, dGTP, and dTIP 
with the active-site amino acid, Y671, plays an intricate role in 
governing nucleotide selection during the replication of an 
abasic site. In fact, these interactions appear to regulate the 
distance between the alpha phosphate of the incoming nu-
cleotide with the 3'-hydroxyl of the primer template. Thus, this 
type of steric fit mechanism ultimately influences the rate for 
the incorporation of these natural nucleotides opposite the 
lesion, However, this steric fit mechanism does not appear to 
be operational with 5-NITP as the non-natural nucleotide does 
not interact with Y671. Instead, the enhanced base-stacking 
properties of 5-NITP "bypass" the normal steric fit mechanism 
favored by KlenTaq_il 9l As a consequence, the higher catalytic 
efficiency for 5-NITP during translesion DNA synthesis is 
thought to represent a noncanonical pathway compared to 
natural dNTPsY 9J 
We acknowledge that the kinetic data presented here 
cannot provide additional insight into the interactions of non-
natural nucleotides with Y671. However, these data can pro-
vide important insight into molecular mechanisms for the rec-
ognition of non-natural nucleotides. In this case, molecular 
models of existing polymerase structures were used to com-
pare and contrast the potential interactions of non-natural nu-
cleotides with specific amino acids in the active sites of the 
E. coli Kienow fragment and HIV-1 RT. The active site of the 
Kienow fragment contains two aromatic amino acids, F762 and 
Y766, that lie approximately 4 A away from the primer termi-
nus (Figure 4A). We argue that these particular amino acids 
create an energetically favorable environment that facilitates 
the binding of hydrophobic non-natural nucleotides such as 5-
NITP and 5-MeCITP. Likewise, these hydrophobic amino acids 
would negatively affect the binding of hydrophilic analogues, 
This is most evident as the catalytic efficiency of 3200 M-1 s-1 
measured with the hydrophilic 5-CITP is approximately ten 
times lower than the hydrophobic isostere, 5-NITP 
(30000 M-1 s-1). This difference, corresponding to a t . t .G value 
of 1.33 kcal mo1-1, likely reflects the energetic contributions of 
nucleobase desolvation during the initial binding step. Similar 
results were obtained with the bacteriophage T4 DNA poly-
merase during the replication of an abasic site as the energetic 
contribution of nucleobase desolvation was greater during 
ground state binding (t.t.G = 1.3 kcal mol-1) compared to the 
rate constant for incorporation (t.t.G = 0.4 kcal mol-1).18J 
In HIV-1 RT, R72 and Ql 51 occupy sites that are equivalent 
to F762 and Y766, respectively, in the Kienow fragment The 
physical differences in these amino acids can partially explain 
the dichotomy in nucleotide selection and utilization between 
either DNA polymerase. For example, the inhibitory effects of 
the hydrophilic analogue, 5-CITP, could be caused by favorable 
interactions with R72 and Ql 51 which are both polar and hy-
drophilic. While 5-CITP binds to HIV-1 RT with reasonably high 
affinity (K; < 10 µM), its inability to be incorporated suggests 
that these interactions with 5-CITP result in a nonproductive 
conformation that prevents phosphoryl transfer. Surprisingly, 
both 5-MeCITP and 5-NITP are incorporated opposite an abasic 
site, albeit with low catalytic efficiencies. The utilization of 5-
MeCITP could reflect favorable hydrogen-bonding interactions 
of its carbonyl moiety with the polar side chains of either 
amino acid, While the nitro moiety of 5-NITP does not partici-
pate in classical hydrogen bonding interactions, it could 
engage in dipole-induced interactions with DNA bases and/or 
polar amino acids that reside in the active site of HIV-1 RT, 
Further studies are required to more accurately evaluate this 
possibility. 
Another unique feature of this study is that hydrophobic nu-
cleotides such as 5-PhlTP can bind to multiple sites on HIV-
1 RT. Specifically, the noncompetitive inhibition displayed by 5-
PhlTP indicates that this hydrophobic analogue binds to the 
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polymerase's active site as well as to a potential allosteric site. 
The structural model provided in Figure 5 A highlights poten-
tial binding interactions of 5-PhlTP within a hydrophobic 
pocket that lies adjacent to the active site. This hydrophobic 
Figure 5. Putative three dimensional structure of HIV 1 RT. A) Structural 
model of HIV 1 RT in complexed with 5 PhlTP (CPK stick representation with 
carbon atoms in magenta) docked in a hydrophobic allosteric site (key resi 
dues are shown in CPK stick representation with carbon atoms in purple 
color) adjacent to the polymerase active site. B) Surface representation of 
HIV 1 RT model highlighting the putative positioning of 5 PhlTP (CPK stick 
representation with carbon atoms in magenta) with respect to key residues 
of the allosteric binding pocket. These models were generated using the 
PyMol Modeling software by first aligning the primary amino acid sequences 
of 1 HMI (HIV 1 RT DNA binary complex) and 3Q09 (HIV 1 RT NNRTI binary 
complex) as further described in the Experimental Section. 
pocket was originally identified as the binding site for non-nu-
cleoside reverse transcriptase inhibitors (NNRTls) including Ne-
virapine and EfavirenzY11 NNRTls do not resemble nucleoside 
analogues and thus function as uncompetitive inhibitors by 
binding to the RT-DNA-dNTP complex as opposed to free RT 
or RT-DNA complexY21 Furthermore, NNRTls bind to a pocket 
that lies - 1  O A from the polymerase's active site and that is 
lined with large and hydrophobic amino acids including Yl  81, 
Y188, F227, and L234.1231 Our modeling studies suggest that 
the 5-phenylindole moiety of 5-PhlTP could also bind in this 
region (Figure 5 A and B). In this model, favorable :rt-:rt stacking 
and hydrophobic interactions could be made between the 5-
phenylindole moiety with several of aromatic residues (Yl 81, 
Y183, Y188, F227, and W229). The binding of 5-PhlTP could 
also be assisted through electrostatic interactions that exist be-
tween the triphosphate group with one or more lysine resi-
dues (K101-K104) that lie within 6-10 A from this hydrophobic 
pocket. In support of this mechanism, the potency of 5-PhlDP, 
the diphosphate form of the non-natural nucleotide, is re-
duced twofold compared to the triphosphate, 5-PhlTP (Fig-
ure 52). We note, however, that additional studies such as 
structural characterizations are needed to firmly establish the 
binding of 5-PhlTP at this site. 
The identification of a non-natural nucleotide that interacts 
with both catalytic and allosteric sites of HIV-1 RT could have 
important implications for developing new therapeutic agents 
against this viral polymerase. For example, nucleoside-based 
inhibitors such as AZT and ddC are often combined with 
NNRTls in order to synergistically reduce viral loads in patients 
infected with HIV. Combining both drugs produces additional 
benefits by delaying the onset of drug resistance caused by 
pyrophosphorolytic removal of conventional chain-terminating 
nucleotidesY41 While therapeutically effective, the use of multi-
ple drug regimens can produce various complications includ-
ing potential toxicity due to adverse drug-drug interactions_l2s1 
The studies here show that 5-PhlTP can function as a single 
chemical entity to inhibit HIV-1 RT through multiple mecha-
nisms. In this respect, the uncompetitive inhibition displayed 
by 5-PhlTP is preferred over conventional inhibitors that work 
in a competitive manner. This preference reflects the difficulty 
in achieving drug resistance against an uncompetitive inhibitor 
since increasing substrate concentrations cannot relieve the in-
hibitory effects of the compound that is commonly observed 
with competitive inhibitors. In addition, the use of a single 
entity to synergistically inhibit HIV-1 RT can reduce complica-
tions arising from pharmacodynamic and pharmacokinetic vari-
ables associated with different drugs. The ability of the corre-
sponding non-natural nucleoside to function as an anti-viral 
agent is currently being investigated. 
Conclusions 
Using several different non-natural nucleotides, we were able 
to demonstrate that high- and low-fidelity DNA polymerases 
utilize distinct molecular features for nucleotide recognition 
and incorporation. In particular, HIV-1 RT appears to utilize 5-
substituted indolyl-nucleotides that are capable of hydrogen-
bonding interactions whereas the high-fidelity Kienow frag-
ment preferentially utilizes hydrophobic analogues rather than 
those that are hydrophilic. Finally, several of the hydrophobic 
analogues display unique inhibitory effects against HIV-1 RT, 
a feature that might be exploited for therapeutic intervention. 
Experimental Section 
Materials: [y-32P]ATP was purchased from PerkinElmer Life Scien-
ces. All oligonucleotides, including those containing a tetrahydro-
furan moiety mimicking an abasic site, were synthesized by 
Operon Technologies (Alameda, CA). Oligonucleotides were puri-
fied as previously described 17•l using denaturing polyacrylamide gel 
electrophoresis for single-strand DNA and native polyacrylamide 
gel electrophoresis for duplex DNA. HIV-1 reverse transcriptase was 
purchased from Calbiochem (San Diego, CA). The Kienow fragment 
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of DNA polymerase I from E. coli was purified and quantified as de-
scribed.126l All non-natural nucleotides were synthesized and char-
acterized as previously described_l8l All other materials were ob-
tained from commercial sources and were of the highest quality 
available. 
Measurements of the kinetic parameters for nucleotide incorpo-
ration: Kinetic parameters (kca,, Km, and k,a/ Km) for natural and 
non-natural nucleotides were obtained as previously described_l8l 
In brief, for the replication of an abasic site, assays were performed 
by preincubating DNA substrate (1000 nM) with variable nucleo-
tide concentrations (O 500 µM) in the presence of Mg2+ (10 mM) 
and initiating the reaction through the addition of E. coli Kienow 
fragment (12 nM). Similar conditions were employed for HIV-1 re-
verse transcriptase. In this case, assays were performed by preincu-
bating DNA substrates (500 nM) with variable nucleotide concen-
trations (0 500 µM) in the presence of Mg2+ (10 mM). Polymeri-
zation reactions were initiated by adding HIV-1 reverse transcrip-
tase (SO nM). Slight modifications to these reaction conditions 
were used to measure nucleotide incorporation opposite an 
unmodified thymine. In this case, assays used Kienow fragment 
(60 nM) and 13/20T-mer DNA substrate (1000 nM) with variable 
nucleotide concentrations (O 500 µM). 
Steady-state rates were obtained from the linear portion of the 
time course and were fit to Equation (1 ): 
rate m t +  b (1) 
where m is the slope of the line and the rate of polymerization re-
action (nM s 1), b is they-intercept, and t is time. Data for the de-
pendency of rate as a function of nucleotide concentration were fit 
to the Michaelis Menten equation (Equation (2)): 
V 
Vmax[dXTP] 
Km + [dXTP] 
(2) 
where v is the rate of product formation (nM s 1), Vmax is the maxi-
mal rate of polymerization, Km is the Michaelis constant for dXTP, 
and [dXTPJ is the concentration of nucleotide substrate. The turn-
over number, k,a,, is Vmax divided by the final concentration of poly-
merase used in the experiment. 
Quantifying the inhibitory effects of non-natural nucleotides: 
The inhibitory effects of non-natural nucleotides on HIV-1 RT activi-
ty was measured using HIV-1 RT (SO nM) and duplex DNA (500 nM) 
containing an abasic site template (DNA5p} or duplex DNA contain-
ing a thymine template (DNAT). A small aliquot containing dATP 
(1.5 µM; opposite T) or dATP (100 µM; opposite SP) and variable 
concentrations (0 500 µM) of non-natural nucleotide was added to 
initiate the polymerization reaction. Aliquots of the reaction were 
quenched with EDTA (200 mM, pH 7.4) at times ranging from 10 
300 s, and product formation was quantified as described above. 
appK; values were obtained using the x-intercept from Dixon plot 
analysis (1 /rate versus inhibitor concentration). True inhibition con-
stants designated as K; values were obtained using Equation (3) 
appK; 
1 + ([dNTP]/Km ) (3) 
where Km is the Michaelis constant for dXTP, and [dNTPJ is the con-
centration of nucleotide substrate, and appK; is the apparent inhib-
ition constant determined from the Dixon plot. All measured K; 
values represent an average of two independent determinations. 
Dead-end inhibition studies were performed by varying the con-
centration of dNTP substrate at several fixed concentrations of 
non-natural nucleotide (O 500 µM). Reciprocal velocities (1/rate) 
were plotted versus reciprocal dNTP concentrations (1/dNTP). All 
plots and replots used to define K; values were linear. Data were fit 
to the following rate equations to validate the mode of inhibition 
and to provide K;, and/or K; values. Data conforming to a competi-
tive inhibition pattern were fit to Equation (4): 
V 
Km [ 
/ 
] 
1 1 
- 1 + - x - - + -
V max K;, [dXTP] V max 
(4) 
data conforming to an uncompetitive inhibition pattern were fit to 
Equation (5): 
V 
- - - + - 1 + -
Km 1 1 [ 
/ 
] v max [ dXTP] V max K;; (5) 
data conforming to a noncompetitive inhibition pattern were fit to 
Equation (6): 
V 
Km [
/ 
] 
1 1 
[ 
/ 
] - 1 + - x - - + - 1 + -
V max K;, [dXTP] V max K;; 
(6) 
Molecular modeling and docking: Coordinates of the crystal 
structures used for molecular modeling were taken from the Re-
search Collaboratory for Structural Bioinformatics Protein Data 
Bank (http://www.pdb.org). Structural models for the putative 
Kienow DNA5p dNTP ternary complex was made from the cocrystal 
structures of Klentaq DNA5p dNTP (PDB ID: 3LWLJ 1
15al since only 
the crystal structures of the binary complexes of the Kienow frag-
ment have been determined in complex with DNA115b,c J or dNTP_l15dJ 
Both enzymes are structurally and functionally homologous_l27l 
Conserved residues of the Kienow fragment corresponding to 
those in the Klentaq fragment were determined through primary 
sequence alignment using the BLOSUM62 substitution matrixi28l 
Hydrophobicity surface models were generated using the Kyte 
Doolittle129l hydrophobicity scale provided in UCSF Chimera 1.s.3_l30l 
The abasic site in HIV-1 RT DNA dNTP (PDB ID: 3KK2J i16l ternary com-
plex was created by removing the templating nucleobase partner of 
the incoming dNTP in the active site and energy minimized through 
molecular mechanics using the Molecular Operating Environment 
(MOE 2010.10) modeling software (http://www.chemcomp.com). 
The MOE program was used for the docking simulation studies as 
well as to search for favorable binding configurations between 5-
PhlTP and the macromolecular target, HIV-1 RT. The coordinates of 
the crystal structure of the macromolecular target, HIV-1 RT bound 
to TSAO inhibitor (PDB ID: 3Q09), were downloaded from RCSB. 
Prior to the docking simulation, the TSAO inhibitor was deleted 
and hydrogens were added to the crystal structure using the stan-
dard settings of MOE's Protonate 3D. The Site Finder application in 
MOE was then used to calculate possible binding sites from the 
three-dimensional atomic coordinates of the enzyme. Sites that in-
clude the residues of the nucleotide and hydrophobic binding 
pockets were selected as potential binding pocket by populating 
them with "dummy atoms" in preparation for the docking simula-
tions with 5-PhlTP. MOE-dock generated a maximum of 1000 poses 
with the Triangle Matcher feature, and the best 30 poses were 
retained for further relaxation and scored based on the Affinity dG 
scoring function of MOE. The best scoring pose was subjected for 
further relaxation and forcefield refinements. 
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Abbreviations 
EDTA: ethylenediaminetetraacetate sodium salt; dNTP: deoxynu-
cleoside triphosphate; T: thymine; dAMP: adenosine-2'-deoxyribo-
side monophosphate; dATP: adenosine-2'-deoxyriboside triphos-
phate; dGTP: guanine-2'-deoxyriboside triphosphate; d T I P :  thy-
mine-2'-deoxyriboside triphosphate; 5-NITP: 5-nitroindolyl-2'-de-
oxynucleoside triphosphate; 5-CITP: 5-carboxylindolyl-2'-deoxy-
nucleoside triphosphate; 5-MeCITP: 5-methylcarboxylindolyl-2'-
deoxynucleoside triphosphate; 5-PhlTP: 5-phenylindolyl-2'-deoxy-
nucleoside triphosphate; 5-FS-PhlTP: 5-pentafluorophenylindolyl-
2' -deoxynucleoside triphosphate; 5-F40Me-PhlTP: 5-tetrafluoro-4-
methoxy-phenylindolyl-2'-deoxynucleoside triphosphate; lndTP: in-
dolyl-2'-deoxynucleoside triphosphate; 5-CHITP: 5-cyclohexyl-2'-de-
oxynucleoside triphosphate. 
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